(Q74244593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Dansette PM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jaoen M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pons C

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Toxicologic Pathology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

145-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

HMGCoA reductase and cholesterol 7 alpha-hydroxylase in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Cytochrome P-450 monooxygenase activities in human and rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2800%2980107-4

7 January 2021

10.1016/S0940-2993(00)80107-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10965989%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference